Munafa Stock Market Course + Intraday & FNO calls 
Champions Oncology (CSBR) Technical (Analysis) Reports Champions Oncology ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Champions Oncology (CSBR)
Technical Analysis Report for NASDAQ stock CSBR Champions Oncology. Dated: 21 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock CSBR Champions Oncology then click here. or read Experts views on Champions Oncology or Forecast & share price targets of Champions Oncology
Champions Oncology Opened at 5.24 and Closed at: 4.96, which is -4.44% of previous session's close. It moved within a range of 4.91 and 5.24
The session was a Bearish session with an average volume of 8100, which is 2.47% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
Support for tomorrow is 4.77 and resistance for tomorrow is 5.1
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 4.83, 4.71 resistance for tomorrow's hourly charts is 5.16, 5.37
10 Day SMA for Champions Oncology (CSBR) is 5.04 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Champions Oncology (CSBR) is 5.25 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Champions Oncology (CSBR) is 5.78 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 5.86 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Champions Oncology is 6.17 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Champions Oncology is at 5.25 and 200 DMA is at 6.17, while 50 DMA and 100 DMA are at 5.78 and 5.86 respectively
Champions Oncology (CSBR) moving average of 20 SMA is at 5.25 and 20 EMA is at 5.25
| Date | Closing Price | 20 SMA | 20 EMA |
| 21 Fri Aug | 4.96 | 5.25 | 5.25 |
| 20 Thu Aug | 5.18 | 5.31 | 5.28 |
| 19 Wed Aug | 4.94 | 5.36 | 5.29 |
| 18 Tue Aug | 5.09 | 5.41 | 5.33 |
| 17 Mon Aug | 5.03 | 5.46 | 5.36 |
| 14 Fri Aug | 5.07 | 5.51 | 5.4 |
Champions Oncology (CSBR) moving average of 50 SMA is at 5.78 and 50 EMA is at 5.56
| Date | Closing Price | 50 SMA | 50 EMA |
| 21 Fri Aug | 4.96 | 5.78 | 5.56 |
| 20 Thu Aug | 5.18 | 5.81 | 5.58 |
| 19 Wed Aug | 4.94 | 5.82 | 5.6 |
| 18 Tue Aug | 5.09 | 5.84 | 5.63 |
| 17 Mon Aug | 5.03 | 5.85 | 5.65 |
| 14 Fri Aug | 5.07 | 5.86 | 5.68 |
Champions Oncology (CSBR) moving average of 100 SMA is at 5.86 and 100 EMA is at 5.79
| Date | Closing Price | 100 SMA | 100 EMA |
| 21 Fri Aug | 4.96 | 5.86 | 5.79 |
| 20 Thu Aug | 5.18 | 5.87 | 5.81 |
| 19 Wed Aug | 4.94 | 5.88 | 5.82 |
| 18 Tue Aug | 5.09 | 5.89 | 5.84 |
| 17 Mon Aug | 5.03 | 5.89 | 5.86 |
| 14 Fri Aug | 5.07 | 5.9 | 5.88 |
Champions Oncology (CSBR) moving average of 200 SMA is at 6.17 and 200 EMA is at 6.22
| Date | Closing Price | 200 SMA | 200 EMA |
| 21 Fri Aug | 4.96 | 6.17 | 6.22 |
| 20 Thu Aug | 5.18 | 6.18 | 6.23 |
| 19 Wed Aug | 4.94 | 6.19 | 6.24 |
| 18 Tue Aug | 5.09 | 6.2 | 6.25 |
| 17 Mon Aug | 5.03 | 6.2 | 6.26 |
| 14 Fri Aug | 5.07 | 6.21 | 6.27 |
Voyager Therapeutics has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Voyager Therapeutics, about 27.86% more returns!
Vistagen Therapeutics has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Vistagen Therapeutics, about 22.5% more returns!
Champions Oncology has performed better than Veracyte Inc in short term. Holding Champions Oncology could be a better choice for now!
Sol Gel has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Sol Gel, about 15.52% more returns!
Sintx Technologies has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Sintx Technologies, about 17.51% more returns!
Ultragenyx Pharmaceutical has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Ultragenyx Pharmaceutical, about 14.21% more returns!
Oncolytics Biotech has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Oncolytics Biotech, about 23.15% more returns!
Atyr Pharma has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Atyr Pharma, about 93.51% more returns!
Kura Oncology has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Kura Oncology, about 35.29% more returns!
Kodiak Sciences has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Kodiak Sciences, about 9.61% more returns!
Kiniksa Pharmaceuticals has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Kiniksa Pharmaceuticals, about 42.55% more returns!
Acadia Healthcare has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Acadia Healthcare, about 3.75% more returns!
Axsome Therapeutics has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 5.31% more returns!
Entera Bio has performed better than Champions Oncology in short term. You could have earned much better returns by investing in Entera Bio, about 0.34% more returns!
National Vision has performed better than Champions Oncology in short term. You could have earned much better returns by investing in National Vision, about 4.36% more returns!
Champions Oncology has performed better than Genprex Inc in short term. Holding Champions Oncology could be a better choice for now!
Champions Oncology Technical analysis of indicators
Price action analysis of Champions Oncology (CSBR) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Champions Oncology stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Champions Oncology in short term but the buy signal is initial and weak.
Champions Oncology Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Champions Oncology in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Champions Oncology is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.05 and Champions Oncology CSBR stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Champions Oncology CSBR stock. Volume based technical analysis of Champions Oncology CSBR stock is negative.
Champions Oncology Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock CSBR Champions Oncology These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CSBR Experts View which covers a lot of information including buying and selling signals
CSBR future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Champions Oncology or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Champions Oncology (CSBR) Technical (Analysis) Reports Champions Oncology ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
